Savas Komban
Investor at Mighty Capital
Palo Alto, California
Overview
Work Experience
Co-Founder and CEO
2018 - Current
Currently serving as the CEO and Co-Founder of Smartlens, Savas leads a late-stage clinical company developing novel solutions for managing glaucoma and other anterior segment eye diseases. Smartlens is transforming traditional eye care into personalized, proactive disease management through technologies addressing unmet needs in ophthalmic care since the 1950s. Its portfolio includes: • a breakthrough, electronics-free contact lens for remote IOP monitoring - addressing a primary risk factor for glaucoma, leading cause of irreversible blindness • a smart drug delivery platform that optimizes treatment timing and patient compliance • an advanced AI-powered imaging platform serving as a smart slit lamp for remote disease management These innovations, protected by patents in over 40 countries and backed by prominent VC firms and Stanford University, have demonstrated strong clinical results with commercialization planned for 2025. Under his leadership, the Company has earned recognition from Nature Medicine, Fortune, and BBC, including the "Outstanding Innovation in Medical Technology and Life Sciences" award at the 2021 High-Tech Awards.
Clinical stage, novel technologies for managing Glaucoma
Raised $6,100,000.00 from Sophia Innovation Capital, Ambit Health Ventures, Stanford University, WS Investments, Graphene Ventures, Plaisance Capital Management, 3E Bioventures and Boutique Venture Partners.
Investor / Partner
2018
Mighty Capital is a Silicon Valley venture capital firm that invests in companies building “products that count:” products that transform lives and create value at scale. Its unique model relies on a handpicked group of experienced founders and executives with significant tenures at remarkable organizations. Everyone invests, shares in the upside and is on deck to help. We bring together the smartest people we know.
Mighty Capital is an early-growth venture capital firm that capitalizes on the growing influence of product management in corporate success.
Advisory Board Member
2020
The bioengineering external advisory board makes meaningful contributions to the bioengineering department in its mission to sustain academic excellence by continually improving curriculum and training our students to become technically competent and prepared to address the ever-changing needs of society. The board plays a critical role in enhancing academia-industry collaborations and recruiting new industry partners to our programs. In particular, the board advocates and promotes our academic programs to local industries and institutes in the Bay Area and beyond. The board also provides input to the department, supporting its teaching, research, and outreach activities. The input is also valuable in planning for new programs and setting directions for the department.
Senior Vice President & Head of Global Business Innovation
2012 - 2017
Savas assumed executive level global roles at NTT Group besides his leadership role at itelligence TR. He established, developed and managed global teams delivering multi hundred million dollar initiatives. He spearheaded the Group's global innovation hub and competence center covering 5 continents.
President and CEO
2012 - 2016
Savas served as President & CEO after making a strategic M&A to Japanese NTT. The organization has developed breakthrough technologies and has been selected as the top digital innovator by SAP, Deloitte and other institutions. Thanks to their unique company culture and accomplished team, he further grew the business 5 times in 4 years and built the pillars for its ongoing sustainable growth. As an executive sponsor for numerous business transformations, Savas worked with leading enterprises in almost every industry and introduced solutions that helped them to adapt and lead in the digital economy.
Co-Founder and CEO
2000 - 2012
Savas founded itelligence TR (former Elsys) with his technical cofounders. He developed and grew the business to a global scale having activities in more than 50 countries. With its team of highly skilled experts, the Company has been selected as one of the fastest growing organizations by Deloitte 7 years in a row. Savas then expanded Group's activities in complementary areas, based on a comprehensive strategy for its further growth and continued leadership in utilizing management science and technology while offering cutting edge business solutions with its exclusive partner SAP. The Group's outstanding success and track record led the way for its acquisition by the Japanese NTT.
Partner Executive Council Member
2007 - 2012
SAP IoT Start up Accelerator is a global co-innovation program for B2B startups innovating in the world of the Internet of Things.
Senior Business Systems and SAP Consultant
1998 - 2000
Savas managed one of the first Business Process Innovation and SAP Supply Chain implementations in the world. As Savas moved on with his entrepreneurial journey, Unilever became his first and long term customer for the next 16 years.